COLON CANCER ADENOCARCINOMA

Clinical trials for COLON CANCER ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new COLON CANCER ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for COLON CANCER ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New Triple-Threat attack on Tough-to-Treat colon cancer

Disease control Recruiting now

This study is testing a new first-line treatment for people with advanced, HER2-positive colorectal cancer that cannot be removed by surgery. It combines three drugs—trastuzumab-deruxtecan, capecitabine, and bevacizumab—to see how well they shrink tumors and control the disease. …

Matched conditions: COLON CANCER ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

COLON CANCER ADENOCARCINOMA

Get alerted when new COLON CANCER ADENOCARCINOMA trials appear

New Triple-Threat attack on Tough-to-Treat colon cancer